Treatment of Refractory Ischemic Pain from Chemotherapy-Induced Raynaud’s Syndrome With Spinal Cord Stimulation
Article first published online: 6 JUN 2007
Volume 7, Issue 2, pages 143–146, June 2007
How to Cite
Ting, J. C., Fukshansky, M. and Burton, A. W. (2007), Treatment of Refractory Ischemic Pain from Chemotherapy-Induced Raynaud’s Syndrome With Spinal Cord Stimulation. Pain Practice, 7: 143–146. doi: 10.1111/j.1533-2500.2007.00122.x
- Issue published online: 6 JUN 2007
- Article first published online: 6 JUN 2007
- Submitted: February 23, 2006; Revision accepted: June 20, 2006
- ischemic limb pain;
- Raynaud’s syndrome;
- spinal cord stimulation;
Abstract: We report the successful treatment of refractory ischemic pain from cisplatin-induced Raynaud’s syndrome with spinal cord stimulation after failed pharmacologic management and surgical sympathectomy.
Case Report: A 48-year-old man developed ischemic pain of the hands while undergoing cisplatin and gemcitabine chemotherapy for metastatic pancreatic carcinoma. After extensive pharmacologic management and surgical sympathectomy failed to provide adequate analgesia, the patient underwent a percutaneous spinal cord stimulation trial followed by permanent implantation and received significant pain relief prior to succumbing to his illness. Spinal cord stimulation provided effective therapy for refractory ischemic pain, even after failed sympathectomy.